Previous close | 5.60 |
Open | 5.60 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 41.00 |
Expiry date | 2024-08-16 |
Day's range | 5.60 - 5.60 |
Contract range | N/A |
Volume | |
Open interest | 404 |
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BP p.l.c. (BP) and Gilead Sciences, Inc. (GILD), as well as two micro-cap stocks Smith-Midland Corporation (SMID) and Crimson Wine Group, Ltd. (CWGL).
BP Plc will evaluate expanding and diversifying its biofuel operation in Brazil, looking at new products such as second-generation ethanol and sustainable aviation fuel after buying out Bunge from their joint venture BP Bunge Bioenergia. The company said in written comments to Reuters that it wants to use the venture's massive biofuel base in Brazil - an industrial complex with 11 plants in five states processing sugarcane - to develop key projects to support the broader BP view for bioenergy. The Brazil complex "is a scalable bioenergy platform with cost advantages," it said.
BP has agreed to buy Bunge's 50% interest in their joint venture (JV), BP Bunge Bioenergia. The $1.4 billion deal will give BP full ownership of the JV, enabling streamlined operations and a refined focus on profitable biofuel developments.